Targeted panels have been shown to be clinically useful in the diagnosis of rare inherited anaemias, including CDA‐I (Gerrard et al, 2013; Roy et al, 2016; Russo et al, 2018; Shefer Averbuch et al, 2018). Here, CDAN1 is linked to anemia.